Dr. Hans-Joachim (Jochen) Boehm, PhD, is co-founder and managing director of the life-science start-up company Novomol. Before creating Novomol, Hans-Joachim was Global Head of Small Molecule Research at Roche pRed. Prior to this, he served in various positions across the Roche organization including the President and Research Site Head of Roche Palo Alto as well as the Head of Non-Clinical Development at Roche Basel. Before joining Roche in 1996, Hans-Joachim held positions with BASF in Ludwigshafen as a Computational Chemist as well as Siemens in Munich, in the field of Microelectronics. He obtained his Ph.D. in Theoretical Chemistry at the University of Karlsruhe in 1984.